Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; CHP; Chronic hypersensitive pneumonia; DILD; Drug-induced interstitial lung disease; IIP; Idiopathic interstitial pneumonia; ILD; Interstitial lung disease; IPF; Idiopathic pulmonary fibrosis; PCV13; 13-valent pneumococcal conjugated vaccine; PPSV23; 23-v
مقالات ISI واکسن پلی ساکارید پنوموکوک 23 ساله (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; pneumococcal conjugate vaccine; pneumococcal polysaccharide vaccine; immunization information system; sickle cell disease; ACIP; Advisory Committee on Immunization Practices; LBF; Live birth file; MCIR; Michigan Care Improvement Registry; MCV4; 4-Valent m
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; PPSV23; 23-valent pneumococcal polysaccharide vaccine; PCV13; 13-valent pneumococcal conjugate vaccine; influenzavaccine; seasonal influenza vaccine; COPD; chronic obstructive pulmonary disease; ADL; activities of daily living; OR; odds ratio; CI; confide
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; 23vPPV; 23-valent pneumococcal polysaccharide vaccine; AEFI; adverse events following immunisation; GPRN; General Practice Research Network; GP; General Practitioner; TGA; Therapeutic Goods Administration; Adverse events following immunisation; Pneumococc
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; AOM; acute otitis media; CI; confidence interval; CRM; cross-reacting material 197; DT; diphtheria toxoid; DTaP; diphtheria, tetanus, acellular pertussis; DTwP; diphtheria, tetanus, whole-cell pertussis; dPly; detoxified pneumolysin; EPA; exotoxin A of Ps
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; ACIP; Advisory Committee on Immunization Practices; CAPiTA; Community-Acquired Pneumonia Immunization Trial in Adults; CPS; capsular polysaccharide; IPD; invasive pneumococcal disease; NIPP; noninvasive pneumococcal pneumonia; PCV7; 7-valent pneumococcal
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Idiopathic nephrotic syndrome (NS); Immunization; Streptococcus pneumoniae; 13-valent pneumococcal conjugate vaccine (PCV13); Vaccine; Enzyme-linked immunosorbent assay (ELISA); AIM; alternative immunosuppressive medication; CI; confidence interval; ELISA
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; 23-Valent pneumococcal polysaccharide vaccine; Community-acquired pneumonia; Efficacy; Meta-analysis; Immunocompetent;
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Pneumococcal polysaccharide vaccine; 23vPPV; hyporesponsiveness; memory BÂ cell; opsonophagocytosis; antibody; CPS; Cell-wall polysaccharide; FiPP; Fiji Pneumococcal Project; MOPA; Multiplexed opsonophagocytic assay; OI; Opsonization index; OPA; Opsonopha
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; 13-Valent conjugated pneumococcal vaccine; 23-Valent pneumococcal polysaccharide vaccine; Crohn's disease; Inflammatory bowel disease; Pneumococcus; Vaccination;
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; AE; adverse event; CAP; community-acquired pneumonia; GMFR; geometric mean fold rise; GMT; geometric mean titer; IPD; invasive pneumococcal disease; OPA; opsonophagocytic activity; PCV13; 13-valent pneumococcal conjugate vaccine; PPSV23; 23-valent pneumoc
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; CAP; community-acquired pneumonia; CURB-65; confusion, uremia, respiratory rate, BP, age ⥠65 years; PPV23; 23-valent pneumococcal polysaccharide vaccine;
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Adaptive immunity; allergic rhinitis; asthma; atopic dermatitis; epidemiology; immune dysfunction; immune incompetence; infection; innate immunity; phenotype; risk; susceptibility; ACIP; Advisory Committee on Immunization Practices; BSI; Bloodstream infec
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Surveillance; Invasive pneumococcal disease; Antimicrobial resistance; Serotype group; 23-valent pneumococcal polysaccharide vaccine; PPV23; S pneumoniae; STG;
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults â¥50â¯years of age: A randomized trial
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; VZV; varicella-zoster virus; HZ; herpes zoster; PHN; postherpetic neuralgia; CDC; United States Centers for Disease Control and Prevention; YOA; years of age; ZVL; zoster vaccine live; RZV; adjuvanted recombinant zoster vaccine; PPSV23; 23-valent pneumoco
23-valent pneumococcal polysaccharide vaccine elicits hierarchical antibody and cellular responses in healthy and tuberculosis-cured elderly, and HIV-1-infected subjects
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; PPV23; OPA; TB-cured elderly; HIV infection; PD; Pneumococcal disease; PPV23; 23-valent pneumococcal polysaccharide vaccine; HIV; human immunodeficiency virus; Mtb; Mycobacterium tuberculosis; IRB; Institutional Review Board; IBC; Institutional Biosafety
Functional immune responses to 11 non-PCV13 serotypes after immunization with a 23-valent pneumococcal polysaccharide vaccine in older adults
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; PPSV23; 23-valent pneumococcal polysaccharide vaccine; IPD; invasive pneumococcal diseases; PCV13; 13-valent pneumococcal conjugate vaccine; OPA; opsonophagocytic assay; MOPA; multiplexed OPA; OBB; opsonization buffer B; BRC; Baby rabbit complement; THY;
Post-licensure safety surveillance of 23-valent pneumococcal polysaccharide vaccine in the Vaccine Adverse Event Reporting System (VAERS), 1990-2013
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; 23-Valent pneumococcal polysaccharide vaccine; Vaccines; Immunizations; Vaccine safety; Surveillance; Vaccine Adverse Event Reporting System (VAERS);
Alterations in serotype-specific B cell responses to the 13-valent pneumococcal conjugate vaccine in aging HIV-infected adults
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; ACIP; Advisory Committee on Immunization Practices; ANOVA; analysis of variance; ART; antiretroviral therapy; BAFF-R; B cell-activating factor receptor; CBC; complete blood count; CD4; CD4+ T cells/μl; HIV; human immunodeficiency virus; Ig; immunoglobuli
The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Effectiveness; 23-Valent pneumococcal polysaccharide vaccine; Elderly; Systematic review, Meta-analysis;
Immunogenicity and safety of concomitant MF59-adjuvanted influenza vaccine and 23-valent pneumococcal polysaccharide vaccine administration in older adults
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; aIIV3; adjuvanted trivalent inactivated influenza vaccine; IIV3; inactivated trivalent influenza vaccine; PPSV23; 23-valent pneumococcal polysaccharide vaccine; PCV13; 13-valent pneumococcal conjugate vaccine; HI; hemagglutination inhibition; GMT; geometr
Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; 23PPV; 23-valent pneumococcal polysaccharide vaccine; AE; adverse event; anti-PD; NTHi protein D antibody; ATP; according to protocol; dPly; pneumolysin toxoid; ELISA; enzyme-linked immunosorbent assay; GMC; geometric mean concentration; GMT; geometric me
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in people aged 65 years and over in the North East of England, April 2006–July 2012
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; 23-Valent pneumococcal polysaccharide vaccine; Invasive pneumococcal disease; Vaccine effectiveness; North East England; Aged ⩾65 years
The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia-Over 22 years
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; CXR; chest X-ray; CLD; chronic lung disease; CRD; chronic renal disease; CAP; community-acquired pneumonia; CI; confidence interval; GLM; generalized linear model; IR; incidence rates; ICU; intensive care unit; IPD; invasive pneumococcal disease; NT; Nort
Pneumococcal vaccination in adults: Does it really work?
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Pneumococcus; Vaccine; Polysaccharide; Conjugate; Efficacy; CAP; Community acquired pneumonia; PPV; Pneumococcal polysaccharide vaccine; PPV23; 23-valent pneumococcal polysaccharide vaccine; PCV; Pneumococcal conjugate vaccine; PCV7; 7-valent pneumococcal
The epidemiologic evidence underlying recommendations for use of pneumococcal polysaccharide vaccine among American Indian and Alaska Native populations
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Streptococcus pneumoniae; 23-Valent pneumococcal polysaccharide vaccine; Native American; Pneumococcus; Alaska Native; American Indian;
Mother-infant vaccination with pneumococcal polysaccharide vaccine: Persistence of maternal antibodies and responses of infants to vaccination
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; 23-Valent pneumococcal polysaccharide vaccine; Infant immunization; Maternal antibodies; Maternal immunization;
Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Atopic dermatitis; allergic rhinitis; serious pneumococcal disease; epidemiology; risk; pneumococcal pneumonia; Rochester Epidemiology Project; ACIP; Advisory Committee on Immunization Practices; IPD; Invasive pneumococcal disease; OR; Odds ratio; PPV-23;
Randomised revaccination with pneumococcal polysaccharide or conjugate vaccine in asplenic children previously vaccinated with polysaccharide vaccine
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; PSV23; 23-valent pneumococcal polysaccharide vaccine; PCV7; heptavalent pneumococcal conjugate vaccine; GMC; geometric mean concentrations; Pneumococcal infection; Prevention; Vaccine; Splenectomy;
Immunogenicity of varying dosages of 7-valent pneumococcal polysaccharide–protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Keywords: واکسن پلی ساکارید پنوموکوک 23 ساله; Pneumococcal vaccines; Pneumococcal conjugate vaccine; 23-Valent pneumococcal polysaccharide vaccine